HB 172, titled the "Defund Heroin Injection Centers Act of 2025," would bar federal funds from going to any state, local, tribal, or private entity that operates or controls an injection center if that center violates section 416 of the Controlled Substances Act, commonly known as the "Crack House Statute" (21 U.S.C. 856). The bill is narrowly drafted and does not create a new regulatory program; instead, it uses the federal spending power to penalize entities involved with unlawful supervised injection sites.
In practical terms, the bill would affect public and private organizations that run or support facilities where controlled substances are used in violation of federal law. It would not amend the Controlled Substances Act itself, but it would add a funding restriction that could reach a broad range of federal grants or assistance flowing to covered entities. The measure is framed as a prohibition on support for injection centers deemed unlawful under existing federal drug law.
Impact
The bill would condition federal funding on compliance with the Controlled Substances Act’s prohibition on maintaining drug-involved premises, potentially affecting state and local governments, tribal entities, nonprofits, and private operators associated with supervised injection or overdose-prevention facilities. Its main legal effect would be to deny federal funds to entities operating such centers in violation of 21 U.S.C. 856, rather than to directly criminalize conduct or redefine the underlying statute. Because it is tied to existing federal law, the bill’s impact would depend on how the "Crack House Statute" is interpreted and enforced in relation to harm-reduction or supervised consumption sites.
Sentiment
No committee discussion or recorded votes were provided, so there is no direct evidence of bipartisan support or opposition in the available record. The bill’s title and text indicate a strongly restrictive stance toward injection centers, suggesting support from lawmakers opposed to supervised consumption sites and likely criticism from harm-reduction advocates. In the absence of transcripts or votes, the overall sentiment can only be characterized as one-sided in the bill’s drafting, with no documented deliberative consensus.
Contention
The central point of contention is whether supervised injection or overdose-prevention centers should be treated as unlawful "injection centers" under federal law and whether federal funding should be withheld from entities associated with them. Supporters are likely to argue that the bill reinforces existing drug prohibitions and prevents federal dollars from subsidizing illegal drug use, while opponents would likely contend that such facilities are public-health interventions aimed at reducing overdose deaths and connecting people to treatment. Another likely dispute is the scope of the funding ban—specifically whether it could sweep in states, localities, tribes, or nonprofits that receive federal funds for unrelated programs but are connected in some way to a covered facility.
Modernizing America with Rebuilding to Kickstart the Economy of the Twenty-first Century with a Historic Infrastructure-Centered Expansion Act Knock Out Cancer Act MARKET CHOICE Act Justice for ALS Veterans Act of 2025 Election Day Act Let America Vote Act SAFER Schools Act of 2024 Secure And Fortify Entrances and Rooms in Schools Act of 2024 KO Cancer Act